Artivion | CRY - Ordinary Share Capital


Artivion reported $47.84M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Accuray USD 100K 1000 Sep/2024
AngioDynamics USD 41.57M 127K Sep/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 50.64M 7K Jun/2026
Baxter International USD 517M 549K Jun/2026
Becton, Dickinson and Co. USD 370.59M 95.05M Jun/2026
Boston Scientific USD 1.48B 2.66M Dec/2025
Edwards Lifesciences USD 577M 3.7M Mar/2026
Inogen USD 23K 0 Dec/2023
Integra LifeSciences USD 77.78M 39K Jun/2026
J&J USD 2.41B 1.35M Mar/2026
Mesa Laboratories USD 349.53M 3.53M Sep/2024
Orthofix International USD 39.83M 315K Dec/2025
Pfizer USD 5.7B 0 Jun/2026
ResMed USD 145.06M 45.78M Jun/2026
Stryker USD 383.4M 416K Jun/2026
Tandem Diabetes Care USD 69.54M 1.04M Jun/2026
Teleflex USD 44.26M 70K Mar/2026
Terumo JPY 1.48B 19K Jun/2026
Trinity Biotech USD 386.76M 1.57M Dec/2025